Relay Therapeutics
RLAY
RLAY
157 hedge funds and large institutions have $2.16B invested in Relay Therapeutics in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 50
5% less funds holding
Funds holding: 165 → 157 (-8)
22% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 32
Holders
157
Holding in Top 10
5
Calls
$5.12M
Puts
$4.35M
Top Buyers
| 1 | +$43.9M | |
| 2 | +$39M | |
| 3 | +$20.2M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$10.8M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$4.68M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$15.3M | |
| 3 | -$12.4M | |
| 4 |
Millennium Management
New York
|
-$8.59M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.33M |